Caitong International Asset Management Co., LTD Anavex Life Sciences Corp. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 297 shares of AVXL stock, worth $2,815. This represents 0.0% of its overall portfolio holdings.
Number of Shares
297
Previous 1,107
73.17%
Holding current value
$2,815
Previous $11.9 Million
78.57%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AVXL
# of Institutions
203Shares Held
31MCall Options Held
1.3MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$60.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$46.5 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$30.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$18.6 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1MShares$9.48 Million0.77% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $739M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...